CDTX vs. NBTX

Last updated Jun 3, 2026

CDTX (Cidara Therapeutics, Inc.) and NBTX (Nanobiotix S.A.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.05 correlation, their price movements are largely independent.

Performance

CDTX vs. NBTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cidara Therapeutics, Inc. (CDTX) and Nanobiotix S.A. (NBTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CDTX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NBTX

• 1D: -3.26%
• 1M: 4.67%
• YTD: 59.00%
• 6M: 79.40%
• 1Y: 796.59%
• 3Y*: 94.06%
• 5Y*: 17.59%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CDTX vs. NBTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CDTX Cidara Therapeutics, Inc.	0.22%	721.76%	69.27%	4.98%	-40.45%	-36.50%	-0.99%
NBTX Nanobiotix S.A.	59.00%	705.57%	-60.58%	98.37%	-54.69%	-50.91%	-2.83%

Correlation

The correlation between CDTX and NBTX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.04
Correlation (All Time) Calculated using the full available price history since Dec 14, 2020	0.05

Fundamentals

EPS CDTX : -$11.88 NBTX : -$1.80
Total Revenue (TTM) CDTX : $0.00 NBTX : $47.94M
Gross Profit (TTM) CDTX : -$45.00M NBTX : $47.94M
EBITDA (TTM) CDTX : -$189.91M NBTX : -$55.82M

Return for Risk

CDTX vs. NBTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBTX

NBTX Risk / Return Rank: 97
NBTX Sharpe Ratio Rank: 99
NBTX Sortino Ratio Rank: 96
NBTX Omega Ratio Rank: 95
NBTX Calmar Ratio Rank: 99
NBTX Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDTX vs. NBTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cidara Therapeutics, Inc. (CDTX) and Nanobiotix S.A. (NBTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CDTX	NBTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	7.33	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.13	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.12	—

Drawdowns

Drawdown Indicators

	CDTX	NBTX	Difference
Max Drawdown Largest peak-to-trough decline	—	-89.94%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-50.25%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-73.88%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-88.87%	—
Current Drawdown Current decline from peak	—	-33.25%	—
Average Drawdown Average peak-to-trough decline	—	-57.56%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	20.74%	—

Volatility

Volatility by Period

	CDTX	NBTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	38.01%	—
Volatility (6M) Calculated over the trailing 6-month period	—	64.35%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	109.76%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	136.75%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	131.87%	—

Dividends

CDTX vs. NBTX - Dividend Comparison

Neither CDTX nor NBTX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CDTX and NBTX in my portfolio?

CDTX and NBTX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.